Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

NET 2Endocrine 2

Conditions

Neuroendocrine Tumors 2Carcinoma, Neuroendocrine 1

Interventions

lutetium Lu 177 dotatate 5Data Collection 3telotristat ethyl 2Somatostatin 2Positron-Emission Tomography 2Magnetic Resonance Spectroscopy 2Everolimus 2Drug Therapy 2Biopsy 2surufatinib 1lanreotide 1copper dotatate CU-64 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sorafenib 1Salvage Therapy 1Radionuclide Imaging 1Radiomics 1Radiofrequency Ablation 1Quality of Life 1Plastic Surgery Procedures 1Phlebotomy 1Patient Reported Outcome Measures 1Octreotide 1Molecular Diagnostic Techniques 1Lutetium-177 1Lutetium 1Liver Transplantation 1Laparoscopy 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Neuroendocrine Tumors × Somatostatin × Clear all
NCT04464122 2025-04-03

REBORN

University of Roma La Sapienza

Recruiting
60 enrolled
EndocrineNET

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT04557137 2020-09-21

Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia

University of Aarhus

Unknown
100 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡